Effects of Intranasal Oxytocin on Emotion Regulation

Trial Profile

Effects of Intranasal Oxytocin on Emotion Regulation

Phase of Trial: Phase I

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Unspecified
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
    • 27 Feb 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
    • 21 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top